P186D

Claim your 1h CE/CME Credit Here
Name*

First NameLast Name
Email*
example@example.com
MD/DORN/NPPAPharmD/RPhRespiratory TherapistNon-Clinician Research CoordinatorOther
medical oncologistsurgical oncologistradiation oncologisthematologistother internisthospitalistprimary care provideremergency medicineOther
NPPICUcath labwardclinicacademicindustryOther
hospital/health system-basedcommunityacademicindustryOther
EU/GBCanadaUSALatin AmericaAustralia/NZAsia
found it on Twitter searching in subject areafound it on twitter searching for CE/CMEfound it on Twitter by following individual influencerfound it on Twitter by following institutional influencerfrom LinkedIn
How many years have you been in practice?
How many patients do you typically see each month?
Patient case #1:
49/F, ECOG PS 0
Dx: High-grade serous Ovarian Cancer Stage IIIA2
Tx: Incomplete resection paclitaxel/carboplatin x 6 cycles PR BRCA mutation
Choice 1: Bevacizumab aloneChoice 2: Bevacizumab + olaparibChoice 3: Olaparib aloneChoice 4: Niraparib alone
Patient case #2:
65/F, ECOG PS 1
Dx: High-grade serous Ovarian Cancer Stage IIIB
Tx: Incomplete resection bevacizumab paclitaxel/carboplatin x 6 cycles CR BRCA mutation, HRD
Choice 1: Bevacizumab aloneChoice 2: Bevacizumab + olaparibChoice 3: Olaparib aloneChoice 4: Niraparib alone
Patient case #3:
66/F, ECOG PS 1
Dx: High-grade serous Ovarian Cancer Stage IIIB
Tx: Complete resection paclitaxel/carboplatin x 6 cycles NED clinical relapse after 1 yr 2L chemo w/o BEV PR BRCA mutation
Choice 1: Bevacizumab aloneChoice 2: Bevacizumab + olaparibChoice 3: Olaparib, rucaparib or niraparib alone
YesNo
YesNo
YesNo
MonthDayYear
Date
Title of Course
Should be Empty: